On Jan. 19, a 35-year-old man in the state of Washington visited an urgent care with a cough and fever. He had just returned to the United States from visiting family in Wuhan, China, the epicenter of the COVID-19 global pandemic.
Nearly 2,500 miles away, scientists inside Columbus’ premier research institution realized they had a problem. Though the virus had yet to spread across the U.S. and become the singular focus of the 24-hour news cycle, the people at Battelle, which plays a key role in the global scientific community, were keenly aware of the outbreak happening in China. A decision was made quickly. Battelle would use its expertise in infectious disease to ramp up development of highly complex tests called assays to support the creation of a vaccine and therapies to treat COVID-19. The research giant’s work, however, didn’t stop there.
Click here to read the complete story.
Story excerpt provided by Columbus CEO.
Written by Laura Newpoff.
Originally published May 2, 2020.